课题基金 / 基金详情

项目摘要

项目成果

Gary L. Pierce的其他基金

相似基金

相关文献

中文摘要
翻译
这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金, 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 在目前的计划中,我们建议检验以下假设:1)在以前久坐不动的中老年人中,定期进行中等强度的有氧运动(每天快走)增加外周管道动脉血流介导的扩张(FMD),这是一种衡量内皮依赖的血管扩张能力和整体动脉血管健康的指标;2)增加一氧化氮(NO)的生物利用度是定期有氧运动改善FMD的关键机制;3)增加NO合成的关键辅助因子四氢生物蝶呤(BH4)的生物利用度是定期有氧运动增加NO生物利用度和FMD的机制之一;4)减少血管氧化应激,部分与增加细胞外超氧化物歧化酶(EcSOD)有关,是有规律有氧运动增加BH4和NO生物利用度和FMD的重要机制;5)动脉内皮细胞特定基因编码蛋白表达的变化(即酶促抗氧化剂eNOS和磷酸化eNOS蛋白表达增加,氧化酶、内皮素-1和血管紧张素II受体蛋白表达减少)是有规律有氧运动对氧化应激、BH4和NO生物利用度和FMD产生有利影响的关键分子机制之一。为了验证这些假设,我们将在久坐不动的健康中老年(年龄55-75岁)男性和女性中进行两个互补的随机有氧运动干预试验。血管氧化应激和BH4的变化在调节FMD改善方面所起的机制作用将在12周运动(或非运动注意力控制)条件之前和之后进行的实验会议中确定。通过一种新的翻译生理学研究技术,将通过定量免疫荧光来确定参与调节这些细胞和系统对习惯性运动的适应的基因的动脉内皮细胞蛋白表达的变化,从而深入了解其中涉及的分子机制。预期的结果将为中等有氧运动恢复中老年久坐成年人动脉内皮功能的有效性及其潜在机制提供新的、临床上重要的见解。特别是,这项拟议的研究将首次提供关于常规运动可能增加NO生物利用度的两种高度新颖的机制的信息:1)通过增加BH4的生物利用度,以及2)通过改变与决定内皮功能有关的关键动脉内皮细胞蛋白的表达。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. In the present plan we propose to test the following hypotheses: 1) regular moderate-intensity aerobic exercise (daily brisk walking) increases peripheral conduit artery flow-mediated dilation (FMD), a measure of endothelium-dependent vasodilatory capacity and overall arterial vascular health, in previously sedentary middle-aged and older adults; 2) an increase in nitric oxide (NO) bioavailability is the key mechanism by which regular aerobic exercise improves FMD; 3) an increase in the bioavailability of the critical co-factor for NO synthesis, tetrahydrobiopterin (BH4), is one mechanism by which regular aerobic exercise increases NO bioavailability and FMD; 4) a reduction in vascular oxidative stress, related in part to an increase in extracellular superoxide dismutase (ecSOD), is an important mechanism by which regular aerobic exercise increases BH4 and NO bioavailability and FMD; 5) changes in the expression of proteins encoded by specific genes in arterial endothelial cells (i.e., increases in enzymatic antioxidant, eNOS, and phosphorylated eNOS protein expressions, and reductions in oxidant enzyme, endothelin-1, and angiotensin II receptor protein expressions) are among the key molecular mechanisms associated with the favorable effects of regular aerobic exercise on oxidative stress, BH4 and NO bioavailability, and FMD. To test these hypotheses we will conduct 2 complementary randomized aerobic exercise intervention trials in sedentary healthy middle-aged and older (age 55-75 years) men and women. The mechanistic roles played by changes in vascular oxidative stress and BH4 and NO bioavailability in mediating improvements in FMD will be determined in experimental sessions conducted before and after a 12-week exercise (or non-exercise attention control) condition. Insight into the molecular mechanisms involved will be obtained using a novel translational physiology research technique by which changes in arterial endothelial cell protein expression of genes involved in the regulation of these cellular and systemic adaptations to habitual exercise will be determined via quantitative immunofluorescence. The expected results will provide new, clinically important insight into the efficacy of moderate aerobic exercise for restoring arterial endothelial function in middle-aged and older sedentary adults, and the underlying mechanisms. In particular the proposed research will provide the first information on 2 highly novel mechanisms by which regular exercise may augment NO bioavailability: 1) by increasing BH4 bioavailability, and 2) by producing changes in the expression of key arterial endothelial cell proteins involved in determining endothelial function.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Sympathetic Regulation of Large Artery Stiffness in Humans with Age-Related Isolated Systolic Hypertension
  • 批准号:
    10400014
  • 项目类别:
  • 资助金额:
    $34.39万
  • 财政年份:
    2020
  • 负责人:
    Gary L. Pierce
  • 依托单位:
Sympathetic Regulation of Large Artery Stiffness in Humans with Age-Related Isolated Systolic Hypertension
  • 批准号:
    10620643
  • 项目类别:
  • 资助金额:
    $34.39万
  • 财政年份:
    2020
  • 负责人:
    Gary L. Pierce
  • 依托单位:
Targeting Inflammation to Treat Cardiovascular Aging in Humans
  • 批准号:
    8583104
  • 项目类别:
  • 资助金额:
    $22.65万
  • 财政年份:
    2013
  • 负责人:
    Gary L. Pierce
  • 依托单位:
Targeting Inflammation to Treat Cardiovascular Aging in Humans
  • 批准号:
    8702981
  • 项目类别:
  • 资助金额:
    $18.88万
  • 财政年份:
    2013
  • 负责人:
    Gary L. Pierce
  • 依托单位:
海外基金